Jan 09, 2026
https://www.streetinsider.com/Business+Wire/Kinaset+Therapeutics+Announces+$103+Million+Oversubscribed+Series+B+Financing+to+Advance+Novel,+Inhaled+Therapeutic+Candidate+for+Respiratory+Diseases/25832532.html
Gimv NV has invested $103M in Kinaset Therapeutics, Inc.